Stockreport

Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

Clearmind Medicine Inc.  (CMND) 
PDF Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech compa [Read more]